Headlands Technologies’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.25M Buy
+49,478
New +$6.52M 0.66% 26
2025
Q4
Sell
-18,310
Closed -$2.03M 730
2025
Q3
$2.03M Buy
+18,310
New +$2.08M 0.16% 142
2025
Q2
Sell
-36,037
Closed -$4.04M 1319
2025
Q1
$4.04M Buy
36,037
+15,539
+76% +$1.6M 0.46% 53
2024
Q4
$1.89M Buy
20,498
+15,220
+288% +$1.37M 0.19% 127
2024
Q3
$443K Sell
5,278
-18,771
-78% -$1.43M 0.05% 366
2024
Q2
$1.65M Buy
24,049
+10,267
+74% +$685K 0.18% 115
2024
Q1
$1.01M Buy
+13,782
New +$1.06M 0.24% 106
2023
Q3
Sell
-31,669
Closed -$2.44M 1034
2023
Q2
$2.44M Buy
+31,669
New +$2.53M 0.78% 22

Other funds holding GILD

Headlands Technologies's GILD Position: Q2 2026 in Review

Headlands Technologies opened a new position in Gilead Sciences (GILD) in Q2 2026: 49,478 shares worth $6.25M. The stake represents 0.66% of the portfolio and ranks #26 among its holdings. This is a return to the name: Headlands Technologies previously reported a position in GILD as recently as Q3 2025.

Headlands Technologies first reported a position in GILD in Q2 2023 and has held it in 8 quarters since. 2,272 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Headlands Technologies held 49,478 shares of Gilead Sciences worth $6.25M as of Q2 2026.
  • Gilead Sciences was a new Headlands Technologies position in Q2 2026.
  • Gilead Sciences made up 0.66% of Headlands Technologies's portfolio in Q2 2026, its #26 holding.
  • Headlands Technologies first reported a position in Gilead Sciences in Q2 2023 and has held it in 8 quarters since.
  • 2,272 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Headlands Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.